CSF β-amyloid is not a prognostic marker in multiple sclerosis patients

Justine Petitfour,Xavier Ayrignac,Nelly Ginestet,Pauline Prin,Clarisse Carra-Dallière,Christophe Hirtz,Mahmoud Charif,Sylvain Lehmann,Pierre Labauge

Multiple Sclerosis and Related Disorders（2022）

引用 3|浏览9

暂无评分

摘要

Our data do not support an association between CSF amyloid levels and MS status and disease severity. We suggest that CSF amyloid levels are not a prognostic biomarker in recently diagnosed RRMS.

查看译文

关键词

Multiple sclerosis,Biomarkers,Prognosis,β-amyloid

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要